Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
出版年份 2015 全文链接
标题
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 1, Pages 125-136
出版商
Wiley
发表日期
2015-07-24
DOI
10.1002/ijc.29698
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines
- (2014) Kwai Fung Hui et al. BRITISH JOURNAL OF HAEMATOLOGY
- Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
- (2014) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Role of ATM in the Formation of the Replication Compartment during Lytic Replication of Epstein-Barr Virus in Nasopharyngeal Epithelial Cells
- (2014) Pok Man Hau et al. JOURNAL OF VIROLOGY
- Microtubule depolymerization activates the Epstein-Barr virus lytic cycle through protein kinase C pathways in nasopharyngeal carcinoma cells
- (2013) Y.-R. Liu et al. JOURNAL OF GENERAL VIROLOGY
- Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
- (2013) K. F. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Multiple roles of class I HDACs in proliferation, differentiation, and development
- (2012) Nina Reichert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cytolytic Virus Activation Therapy for Epstein-Barr Virus-Driven Tumors
- (2012) M. A. Wildeman et al. CLINICAL CANCER RESEARCH
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- The Cellular Ataxia Telangiectasia-Mutated Kinase Promotes Epstein-Barr Virus Lytic Reactivation in Response to Multiple Different Types of Lytic Reactivation-Inducing Stimuli
- (2012) S. R. Hagemeier et al. JOURNAL OF VIROLOGY
- A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax®)
- (2012) Simon J Harrison et al. Epigenomics
- Establishment and characterization of six human gastric carcinoma cell lines, including one naturally infected with Epstein-Barr virus
- (2012) Ja-Lok Ku et al. CELLULAR ONCOLOGY
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Conserved Herpesvirus Kinases Target the DNA Damage Response Pathway and TIP60 Histone Acetyltransferase to Promote Virus Replication
- (2011) Renfeng Li et al. Cell Host & Microbe
- Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
- (2010) Jasmine Zain et al. INVESTIGATIONAL NEW DRUGS
- Interplay between PKC and Sp1 on Histone Deacetylase Inhibitor-Mediated Epstein-Barr Virus Reactivation
- (2010) P.-F. Tsai et al. JOURNAL OF VIROLOGY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cellsin vitro
- (2009) Vivian Wai Yan Lui et al. INTERNATIONAL JOURNAL OF CANCER
- Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells
- (2008) Chih-Yeu Fang et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More